Continuing Education in Opioid Prescribing, JAMA, A Letter from Murray Kopelow, MD, ACCME President and Chief Executive

December 18, 2012
Posted by: 
Tamar Hosansky

"Continuing Education in Opioid Prescribing,” a letter from Murray Kopelow, MD, ACCME President and Chief Executive, published in JAMA, The Journal of the American Medical Association, November 28, 2012, describes the rigorous standards for independence that accredited providers are required to meet when developing CME related to the FDA Extended-Release and Long-Acting Opioid Analgesics Risk Evaluation and Mitigation Strategy. (The full text of the letter is available free to subscribers; nonsubscribers can purchase online access.)